The key role played by TNFα in RA was studied extensively through therapeutic use of anti-TNFα monoclonal antibodies like infliximab or the use of fusion proteins trapping soluble TNFα, like etanercept. This evidence concerns the gene TNF and rheumatoid arthritis.